This program is funded by an independent grant from Novo Nordisk. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.

Join us for this online teaching session presented by Dr. David Chascsa, a leading expert in the field of MASLD & MASH. Dr. David Chascsa will focus on the latest updates and clinical trials relating to non-invasive monitoring techniques for patients with MASH.

Session Overview

Dr. Chascsa will present the latest advances and clinical trials for non-invasive monitoring of MASH. This session will provide valuable insights into the use of biomarkers and imaging techniques, equipping attendees with the skills needed to assess disease progression and treatment efficacy.

Apply Non-Invasive Monitoring Techniques:

Gain proficiency in utilizing current biomarkers and advanced imaging techniques for routine monitoring of patients with MASH. Learn how these tools can effectively track disease progression.

Interpret and Act Upon Test Results:

Develop the ability to accurately interpret test results and make informed decisions to adjust treatment plans. Ensure that treatment strategies are grounded in the most current evidence and tailored to individual patient responses.

Who is this course for

This online education program has been designed solely for healthcare professionals in the USA. The course provides continuing education for:

✅ Gastroenterologists

✅ Hepatologists

✅ Primary Care Physicians

✅ Endocrinologists

✅ Cardiologists

✅ Nurse Practitioners

✅ Physician Assistants

✅ Dietitians/Nutritionists

✅ Pharmacists

✅ Other Health Professionals

Speaker

Dr. David Chascsa

Dr. David M.H. Chascsa is a gastroenterologist, internist, and transplant hepatologist at Mayo Clinic Arizona, specializing in MASLD, MASH, and liver transplantation. He completed his transplant hepatology fellowship at Mayo Clinic in 2017 and is board-certified in transplant hepatology and gastroenterology. Recognized for his excellence in patient care and education, he received Mayo Clinic's Teacher of the Year award in 2022. Dr. Chascsa also serves on the Mayo Clinic Arizona Transplant Center's Education Committee.

Continuing Education Information

This continuing education activity is provided by AffinityCE and MedAll. This activity provides continuing education credit for physicians, physician assistants, nurses, and nurse practitioners and pharmacists. A statement of participation is available to other attendees.

Faculty, planners, and staff disclosure information

AffinityCE/MedAll staff and the planners and reviewers of this educational activity have no relevant financial or non-financial interests to disclose.

David Chascsa

No relevant financial relationships with ineligible companies to disclose.

No unapproved product related discussions to disclose.

Tony Villiotti

Consultant: Madrigal Pharmaceuticals & Regeneron.

No unapproved product related discussions to disclose.

Mitigation of Relevant Financial Relationships

AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible companies. Relevant financial relationships were mitigated by the peer review of content by non-conflicted reviewers prior to the commencement of the program.

Activity Accreditation for Health Professions

Physicians This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and Medall. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Continuing Nursing Education is provided for this program through the joint providership between MedAll and AffinityCE. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This live activity provides a maximum of 1.5 hours of continuing nursing education credit.

Criteria for Claiming CNE Credit: Participants must have registered and attended the entire program. Attendance is monitored online for participation in the entire activity.

Pharmacists

Pharmacists AffinityCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE).

CE Title: MASH Academy: Non-invasive monitoring techniques for patients with MASH

UAN: 0829-9999-24-440-L01-P

Activity Type: Knowledge-based

CEUs: 1.5

No cost to participate.

Participant CE records will be electronically communicated to CPE Monitor.

Pharmacist Learning Objectives

At the conclusion of this web conference, participants should be able to:

• Apply non-invasive monitoring techniques to assess disease progression and treatment efficacy

• Understand the use of current biomarkers and imaging techniques for routine patient monitoring

• Interpret and act upon test results to inform and adjust treatment plans, ensuring they are based on the most current evidence and patient response.

Criteria for Claiming CPE Credit: Participants must have registered and attended the entire program. Attendance is monitored online for participation in the entire activity.

System Requirements

Mobile device (e.g., large-format smart phone; laptop or tablet computer) or desktop computer with a video display of at least 1024 × 768 pixels at 24-bit color depth, capable of connecting to the Internet at broadband or faster speeds, with a current version Internet browser and popular document viewing software (e.g., Microsoft Office, PDF viewer, image viewer) installed. Support for streaming or downloadable audio-visual materials (e.g., streaming MP4, MP3 audio) in hardware and software may be required to view, review, or participate in portions of the program

Other Health Care Professionals All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

Participation Costs

There is no cost to participate in this program.

CME Inquiries

For all CME policy-related inquiries, please contact us at ce@affinityced.com.